Marjan M Hashemi
Overview
Explore the profile of Marjan M Hashemi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tjandra K, Ram-Mohan N, Abe R, Hashemi M, Lee J, Chin S, et al.
Antibiotics (Basel)
. 2022 Apr;
11(4).
PMID: 35453262
Bloodstream infections (BSI) are a leading cause of death worldwide. The lack of timely and reliable diagnostic practices is an ongoing issue for managing BSI. The current gold standard blood...
2.
Ram-Mohan N, Kim D, Zudock E, Hashemi M, Tjandra K, Rogers A, et al.
Clin Infect Dis
. 2021 May;
74(2):218-226.
PMID: 33949665
Background: The determinants of coronavirus disease 2019 (COVID-19) disease severity and extrapulmonary complications (EPCs) are poorly understood. We characterized relationships between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNAemia and...
3.
Hashemi M, Ram-Mohan N, Yang X, Andini N, Gessner N, Carroll K, et al.
J Clin Microbiol
. 2021 Apr;
59(3).
PMID: 33826529
No abstract available.
4.
Ram-Mohan N, Kim D, Zudock E, Hashemi M, Tjandra K, Rogers A, et al.
medRxiv
. 2021 Jan;
PMID: 33398290
Background: The determinants of COVID-19 disease severity and extrapulmonary complications (EPCs) are poorly understood. We characterise the relationships between SARS-CoV-2 RNAaemia and disease severity, clinical deterioration, and specific EPCs. Methods:...
5.
Hashemi M, Ram-Mohan N, Yang X, Andini N, Gessner N, Carroll K, et al.
J Clin Microbiol
. 2020 Sep;
58(12).
PMID: 32967905
The rise of antimicrobial-resistant pathogens can be attributed to the lack of a rapid pathogen identification (ID) or antimicrobial susceptibility testing (AST), resulting in delayed therapeutic decisions at the point...
6.
Yang X, Hashemi M, Andini N, Li M, Kuang S, Carroll K, et al.
J Antimicrob Chemother
. 2020 Mar;
75(7):1747-1755.
PMID: 32191305
Objectives: Traditional antimicrobial susceptibility testing (AST) is growth dependent and time-consuming. With rising rates of drug-resistant infections, a novel diagnostic method is critically needed that can rapidly reveal a pathogen's...
7.
Hashemi M, Holden B, Coburn J, Taylor M, Weber S, Hilton B, et al.
Front Microbiol
. 2019 Mar;
10:210.
PMID: 30833936
Use of chlorhexidine in clinical settings has led to concerns that repeated exposure of bacteria to sub-lethal doses of chlorhexidine might result in chlorhexidine resistance and cross resistance with other...
8.
Hashemi M, Mmuoegbulam A, Holden B, Coburn J, Wilson J, Taylor M, et al.
Int J Environ Res Public Health
. 2018 Dec;
15(12).
PMID: 30563216
The continuous emergence of multidrug resistant pathogens is a major global health concern. Although antimicrobial peptides (AMPs) have shown promise as a possible means of combatting multidrug resistant strains without...
9.
Hashemi M, Rovig J, Holden B, Taylor M, Weber S, Wilson J, et al.
J Antimicrob Chemother
. 2018 Apr;
73(6):1537-1545.
PMID: 29635279
Background: Candida auris has emerged as a serious threat to human health. Of particular concern are the resistance profiles of many clinical isolates, with some being resistant to multiple classes...
10.
Hashemi M, Holden B, Taylor M, Wilson J, Coburn J, Hilton B, et al.
Molecules
. 2018 Mar;
23(3).
PMID: 29518893
Ceragenins were designed as non-peptide mimics of endogenous antimicrobial peptides, and they display broad-spectrum antibacterial and antifungal activities, including the ability to eradicate established biofilms. These features of ceragenins make...